CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- FinancialsAltman Z-Score 3.15: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
2.58%Below 5Y avg (2.76%)
Annual Rate
CNY 0.30Paid annual
Payout Ratio
250.0%High
Payback Period
38.5 yr
Last Ex-Dividend
May 28, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.49BCNY519.11M · vs all stocks (USD)
Trailing P/E
58.00xvs Medical Instruments & Supplies peers
Revenue (TTM)
1.65BCNY246.09M · vs all stocks (USD)
Profit Margin
3.46%vs Medical Instruments & Supplies peers
Beta
-0.1580xvs all stocks
52-Week Change
-20.26%vs all stocks
Market Capitalization
3.49BCNY519.11M · vs all stocks (USD)
Enterprise Value
3.58BCNY532.85M · vs all stocks (USD)
Trailing P/E
58.00xvs Medical Instruments & Supplies peers
Forward P/E
9.67xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
2.05xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
1.90xvs Medical Instruments & Supplies peers
Enterprise to Revenue
2.17xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
10.35xvs Medical Instruments & Supplies peers
Gross Margin
40.65%vs Medical Instruments & Supplies peers
Profit Margin
3.46%vs Medical Instruments & Supplies peers
Operating Margin
14.30%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
6.10%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
3.72%vs Medical Instruments & Supplies peers
Revenue (TTM)
1.65BCNY246.09M · vs all stocks (USD)
Revenue per Share (TTM)
5.67CNYUpdated Aug 21, 2026Quarterly Revenue Growth
3.70%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
716.98MCNY106.62M · vs all stocks (USD)
EBITDA (TTM)
283.41MCNY42.15M · vs all stocks (USD)
Net Income (TTM)
57.25MCNY8.51M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-32.30%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
456.63MCNY67.91M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
81.20MCNY12.07M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.3000CNYUpdated Aug 21, 2026Trailing Annual Dividend Yield
2.58%vs all stocks
5-Year Average Dividend Yield
2.76%vs all stocks
Payout Ratio
250.00%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
14.85MCNYFY2025 · Dec 31, 2025Revenue
1.63BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
901.44MCNYFY2025 · Dec 31, 2025Gross Profit
729.74MCNYFY2025 · Dec 31, 2025Operating Income
304.60MCNY45.30M · vs all stocks (USD)
Pre-tax Income
130.28MCNYFY2025 · Dec 31, 2025Income Tax Expense
43.16MCNYFY2025 · Dec 31, 2025Net Income
87.13MCNYFY2025 · Dec 31, 2025EBIT
148.47MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
396.24MCNYFY2025 · Dec 31, 2025Research & Development
115.66MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
95.58MCNYFY2025 · Dec 31, 2025Other Operating Expenses
28.33MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
6.57MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
18.19MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.2600CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.2600CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
293.57MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
293.57MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
87.13MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-10.80MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
73.33MCNYFY2025 · Dec 31, 2025Free Cash Flow
-132.50MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
239.16MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
87.13MCNYFY2025 · Dec 31, 2025Other Non-cash Items
25.53MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-10.11MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-29.22MCNYFY2025 · Dec 31, 2025Capital Expenditures
-205.83MCNYFY2025 · Dec 31, 2025Purchase of Investments
-531.50MCNYFY2025 · Dec 31, 2025Sale of Investments
487.76MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-249.57MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
208.88MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-124.74MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-159.20MCNYFY2025 · Dec 31, 2025Other Financing Charges
-36.25MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-111.30MCNYFY2025 · Dec 31, 2025Shares Outstanding
291.87MSharesUpdated Aug 21, 2026Float Shares
142.57MSharesUpdated Aug 21, 2026% Held by Insiders
51.15%vs all stocks
% Held by Institutions
6.97%vs all stocks
Total Cash (MRQ)
434.60MCNY64.63M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.49CNYUpdated Aug 21, 2026Total Debt (MRQ)
619.92MCNY92.19M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.3462xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
1.74xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
6.09CNYUpdated Aug 21, 2026Total Assets
2.86BCNY425.37M · vs all stocks (USD)
Total Current Assets
967.19MCNYFY2025 · Dec 31, 2025Total Liabilities
1.08BCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.89BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
446.24MCNYFY2025 · Dec 31, 2025Total Current Liabilities
637.65MCNYFY2025 · Dec 31, 2025Cash
239.16MCNYFY2025 · Dec 31, 2025Cash Equivalents
14.80MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
253.96MCNYFY2025 · Dec 31, 2025Other Short-term Investments
265.09MCNYFY2025 · Dec 31, 2025Accounts Receivable
212.15MCNYFY2025 · Dec 31, 2025Inventory
189.05MCNYFY2025 · Dec 31, 2025Accounts Payable
203.45MCNYFY2025 · Dec 31, 2025Short-term Debt
203.71MCNYFY2025 · Dec 31, 2025Other Current Liabilities
2.68MCNYFY2025 · Dec 31, 2025Long-term Debt
395.80MCNYFY2025 · Dec 31, 2025Common Stock (Book)
291.87MCNYFY2025 · Dec 31, 2025Retained Earnings
687.17MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.78BCNY264.19M · vs all stocks (USD)
Treasury Stock
0.00CNYFY2025 · Dec 31, 202552-Week Low
10.75CNYUpdated Aug 21, 202652-Week High
16.42CNYUpdated Aug 21, 202652-Week Change
-20.26%vs all stocks
Beta
-0.1580xvs all stocks
50-Day MA
11.71CNYUpdated Aug 21, 2026200-Day MA
13.50CNYUpdated Aug 21, 2026Avg 10-Day Volume
6.00MSharesUpdated Aug 21, 2026Avg 30-Day Volume
5.51MSharesUpdated Aug 21, 2026Diluted EPS (TTM)
0.2000CNYUpdated Aug 21, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.41Profit Margin: 0.03
Financial Health
Altman Z-Score 3.15: safe zoneNotable
Altman Z-Score: 3.15
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Healthcare Co Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Chengdu Zhimingda Electronics Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Nantong Jiangtian Chemical Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Chin-Poon Industrial Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Anhui Tuoshan Heavy Industry Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Sinon Corporation
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Sichuan Zhongguang Lightning Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleRisk
Dymatic Chemicals Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Chengdu Screen Micro-Electronics Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Kehua Holdings Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Companies that share active interpretations — structural patterns currently present in both stocks.
Silicon2 Co. Ltd.
1 interpretationMulti-Year Revenue, Profit, And Income Growth
Dongguan Aohai Technology Co., Ltd.
1 interpretationMulti-Year Revenue, Profit, And Income Growth
Bestway Marine & Energy Technology Co. Ltd.
1 interpretationMulti-Year Revenue, Profit, And Income Growth